関連する実験動画
Updated: Jul 19, 2026

10:08
Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
人間の脳からアミロイド前駆体タンパク質ベータ・セクレタゼの浄化とクローン化
S Sinha1, J P Anderson, R Barbour
1Elan Pharmaceuticals, South San Francisco, California 94080, USA. ssinha@elanpharama.com
Nature
|December 11, 1999
まとめ
研究者らは,ヒトの脳内のアミロイド前駆タンパク質 (APP) のベータ分泌酵素分裂に起因する主要な酵素を特定した. この発見は,アルツハイマー病 (AD) の病原性および潜在的な治療標的の理解を前進させる.
科学分野:
- 神経科学は神経科学である.
- バイオケミストリー バイオケミストリー
- 遺伝学 遺伝学とは
背景:
- アルツハイマー病 (AD) は,アミロイド前駆体タンパク質 (APP) 処理から生成されるアミロイドβ (Abeta) ペプチドと関連しています.
- APPのベータ分泌酵素分裂は,アベタ形成とADの病理学における重要なステップです.
- 特定のAPP変異 (スウェーデン語) はベータ分泌酵素の活性を増大させ,家族性ADにおけるその役割を強調する.
研究 の 目的:
- 人間の脳におけるAPPのベータ分泌酵素分裂に起因する酵素を特定し,特徴づけること.
- この酵素の性質とアルツハイマー病におけるその役割を調査する.
主な方法:
- サブストラットアナログ阻害剤を用いて,人間の脳から膜に結合した酵素活性を浄化する.
- 精製された酵素の性質の特徴.
- 特定された酵素のクローン化と発現.
主要な成果:
- ヒトの脳におけるAPPのβ分裂に主として責任を負う膜結合酵素の活性が特定されました.
- 精製された酵素は,β-セクレタゼと一致する性質を示した.
- この酵素は,新しい膜に結合するアスパルティックタンパク質酵素である.
結論:
- 人間の脳におけるベータ・セクレターゼの活動が優勢であることが精製され,特徴づけられました.
- この酵素は新しい膜結合アスパルティックプロテインアゼであり,アベタ生成に不可欠です.
- この発見は,アルツハイマー病の治療戦略に新たなターゲットを提供している.
関連する概念動画
Protein Digestion
Protein digestion begins in the stomach, where the highly acidic environment can easily disrupt protein structure by exposing the peptide bonds of polypeptide chains. After polypeptide chains are broken into individual amino acids by a series of digestive enzymes, the amino acids are transported to the liver via the bloodstream to produce energy.
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Proteins: From Genes to Degradation
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA molecules by RNA...
Transcription is the synthesis of RNA molecules by RNA...
Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...

